142
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Retinoic acid shows direct parasiticidal activity by targeting ergosterol pathway in Leishmania donovani: a potential therapeutic advancement

ORCID Icon & ORCID Icon
Pages 14473-14483 | Received 21 Jul 2022, Accepted 12 Feb 2023, Published online: 28 Mar 2023
 

Abstract

Visceral leishmaniasis (VL) is an infectious disease caused by Leishmania donovani parasite in Indian subcontinent and is life-threatening. It primarily inflicts the malnourished population. There is little therapeutic advancement in the last one decade or more, as the available drugs show adverse effects, complex long treatment, high cost and drug resistance. Here, in a concerted approach, we intended to address the malnutrition as well as the parasite load with a single modality. Our earlier findings show the protective effects of retinoic acid (RA) in controlling the parasite load in infected macrophages (mφ) and restores their M1 phenotype. RA also restores the levels of cellular cholesterol in infected mφ. In this process, we observed loss of ergosterol in the parasite upon treatment with RA. Hence, we hypothesized that RA, besides boosting the parasiticidal mechanism in mφ, may also target the sterol pathway in the parasite by targeting sterol 24-C methyltransferase (SMT). SMT plays an essential role in the formation of ergosterol, required for growth and viability in Leishmania species. Therefore, we predicted as well as validated the 3D structure of SMT protein and performed the quality check. RA showed −9.9 free binding energy towards SMT which is higher than any of its derivatives. The molecular dynamics showed stable conjugate and the in vitro testing showed a reduction by ∼ twofold in the parasite number upon RA treatment. Importantly, it showed a loss of ergosterol possibly due to the inhibition of SMT protein. Our finding showed direct parasiticidal function of RA which is of significance in terms of therapeutic advancement.

Communicated by Ramaswamy H. Sarma

Disclosure statement

No potential conflict of interest was reported by the authors.

Authors’ contributions

All the experiments, analysis, interpretation of data and manuscript preparation were accomplished by SP. AKR conceptualized, designed the workplan, was involved in the data analysis and interpretation, edited the manuscript and also managed the funding’s. All authors contribute to the preparation of the manuscript and approved the submitted version.

Additional information

Funding

We thank Dr. Amogh A. Saharabuddhe (Central Drug Research Institute, Lucknow, India) for providing J774A.1 cell line and Leishmania donovani parasites (DD8 strain). The study was partially supported by MNNIT Allahabad [134/R&C/13-14] and Department of Science and Technology (DST), Government of India [SB/YS/LS-234/2013]. We also acknowledge the Central Facility of the Department of Biotechnology (MNNIT Allahabad, Prayagraj, India) for providing Real-Time PCR facility and other resources. Authors also acknowledge the DST-FIST facility in the department.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.